
MRVI DEADLINE ALERT: Maravai LifeSciences (MRVI) Investors with Losses Encouraged to Contact Hagens Berman Before May ...
SAN FRANCISCO, April 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) reported its fourth-quarter 2024 earnings, missing analyst expectations and prompting a significant downward revision of its price target by at least one …